paper-with-me

홈 › Papers

Molecular Communications in Viral Infections Research: Modelling, Experimental Data and Future Directions

2020-10-30 · Michael Taynnan Barros, Mladen Veletić, Masamitsu Kanada, Massimiliano Pierobon, Seppo Vainio, Ilangko Balasingham, Sasitharan Balasubramaniam

Hundreds of millions of people worldwide are affected by viral infections each year, and yet, several of them neither have vaccines nor effective treatment during and post-infection. This challenge has been highlighted by the COVID-19 pandemic, showing how viruses can quickly spread and how they can impact society as a whole. Novel techniques that bring in different disciplines must emerge to provide forward-looking strategies to combat viral infections, as well as possible future pandemics. In the past decade, an interdisciplinary area involving bioengineering, nanotechnology and information and communication technology (ICT) has been developing, known as Molecular Communications. This new emerging area uses elements of classical communication systems and maps it to molecular signalling and communication found inside and outside the body, where the aim is to develop new tools that can serve future medicine. In this paper, we provide an extensive and detailed discussion on how Molecular Communications can be integrated into the research on viral infectious diseases modelling, and how possible treatment and vaccines can be developed considering molecules as information carriers. We provide a literature review on the existing models of Molecular Communications for viral infection (in-body and out-body), a deep analysis on their effects on the host and subsequent communication process for other systems within the body (e.g., immune response), sources of experimental data on known viral infections and how it can be used by the Molecular Communications community, as well as open issues and future directions. Since the development of therapeutics/vaccines needs an interdisciplinary approach centred around ICT, we are confident that Molecular Communications can play a central role here by providing a detail characterisation and manipulation of the propagation of molecules in different media.

📄 PDF Abstract BibTeX arXiv:2011.00002

Code (0)

등록된 구현이 없습니다.

Similar Papers 제목 키워드 기반

Should public health policy exempt cases with low viral load from isolation during an epidemic?: a modelling study

2024-12-23 · Jiahao Diao, Rebecca H. Chisholm, Nicholas Geard, James M. McCaw

During the COVID-19 pandemic, case isolation emerged as a key non-pharmaceutical intervention in pandemic response. Its effectiveness hinges on the timing of isolation, which is often dictated by the onset of contagiousn…

Spatially-Structured Models of Viral Dynamics: A Scoping Review

2025-03-05 · Thomas Williams, James M. McCaw, James M. Osborne

There is growing recognition in both the experimental and modelling literature of the importance of spatial structure to the dynamics of viral infections in tissues. Aided by the evolution of computing power and motivate…

Drug Repurposing For SARS-COV-2 Using Molecular Docking

2022-06-02 · Imra Aqeel, Abdul Majid, Muhammad Ismail, Hina Bashir

Drug repurposing is an unconventional approach that is used to investigate new therapeutic aids of existing and shelved drugs. Recent advancement in technologies and the availability of the data of genomics, proteomics, …

Molecular Docking

Therapeutic Interfering Particles Exploiting Viral Replication and Assembly Mechanisms Show Promising Performance: A Modelling Study

2021-08-04 · Farzad Fatehi, Richard J. Bingham, Pierre-Philippe Dechant, Peter G. Stockley 외

Defective interfering particles arise spontaneously during a viral infection as mutants lacking essential parts of the viral genome. Their ability to replicate in the presence of the wild-type (WT) virus (at the expense …

In silico Prediction of Mozenavir as potential drug for SARS-CoV-2 infection via Binding Multiple Drug Targets

2021-06-10 · Estari Mamidalaa, Rakesh Davella, Swapna Gurrapu, Munipally Praveen Kumar 외

Since the epidemic began in November 2019, no viable medicine against SARS-CoV-2 has been discovered. The typical medication discovery strategy requires several years of rigorous research and development as well as a sig…

BlockingMolecular Docking